评估TP53多态和单元型对生物电阻分析参数和伊朗人口老龄化中的营养状况的影响
Nima Montazeri-Najafabady1, Mohammad Hossein Dabbaghmanesh2,3, Naeimehossadat Asmarian4
1Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Molecular biology reports
|June 7, 2025
概括
TP53基因变异和单基因类型与伊朗老年人的肉症指标有关. 特定的TP53多态影响营养状况和生物电阻分析 (BIA) 参数,这表明基因在与年龄相关的肌肉衰退中的作用.
科学领域:
- 遗传学和衰老研究研究
- 分子生物学和老年学.
背景情况:
- 肉症是一种与年龄相关的肌肉损失,严重影响老年人的生活质量.
- 调查TP53变体等遗传因素对于了解肉类的发展至关重要.
研究的目的:
- 检查TP53遗传变异 (rs1625895,rs1042522,rs17878362) 和具有肉类症指标的单元类型之间的关联.
- 评估这些TP53变体与生物电阻分析 (BIA) 参数和老年伊朗人的营养状况之间的关系.
主要方法:
- 三种特定TP53变异的基因型化 (rs1625895,rs1042522,rs17878362) 和单种型分析.
- 对生物电阻分析 (BIA) 参数的测量和对伊朗老年人的营养状况的评估.
主要成果:
- 与营养状况相关的TP53 rs1625895变种 (P=0.017).
- TP53 Arg72Pro多态 (rs1042522) 影响了小牛的周长,蛋白质,矿物质,体细胞质量 (BCM) 和手臂肌肉周长 (AMC).
- 在TP53单元型中,蛋白质,矿物质,无脂肪质量 (FFM),BCM和骨矿物质含量 (BMC) 存在显著差异.
结论:
- TP53多态和单元类型可能会影响与肌肉健康和肉症相关的BIA衍生参数.
- 研究结果表明,复杂的基因对生理衰老和肌肉质量有着复杂的影响.
- 需要进一步的研究来探索将TP53变体与肉症联系起来的潜在机制.
相关概念视频
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198